logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
Clinical Lymphoma Myeloma and Leukemia 封面图

Clinical Lymphoma Myeloma and Leukemia

IF2.7
论文数428
被引数4175
期刊论文 428
发表时间
delete
Corrigendum to’ HL-091: Real-World Experience of Pembrolizumab in Relapsed or Refractory Hodgkin Lymphoma: Data From the Anti-Cancer Center of Béchar, Algeria [Clinical Lymphoma Myeloma and Leukemia 26S1 (2026) S839]勘误：HL-091：帕博利珠单抗在复发或难治性霍奇金淋巴瘤中的真实世界经验：来自阿尔及利亚贝沙尔抗癌中心的数据 [临床淋巴瘤骨髓瘤和白血病 26S1 (2026) S839]
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-28
delete0
PREAI
deleteNadjia Benkhira; Fatema Nessal; Soumia Atilah
delete分享
delete收藏
BCMA-directed antibodies in multiple myeloma: new agents and treatment strategies from IMS 2026BCMA靶向抗体在多发性骨髓瘤中的应用：IMS 2026会议的新药物和治疗策略
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-28
delete0
PREAI
deleteYuping Si; Changnian Li; Li Hou
delete分享
delete收藏
Ataxia and Balance Disorders Associated with GPRC5D-Directed Therapies in Relapsed/Refractory Multiple Myeloma: A Case Series with Practical Recommendations for Management共济失调和平衡障碍与GPRC5D靶向疗法在复发/难治性多发性骨髓瘤中的关联：一份病例系列及管理实用建议
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-27
delete0
PREAI
deleteJa Min Byun; Vania Hungria; Niels W.C.J. van de Donk; Emma Searle; Susan Bal; Jing Christine Ye; María-Victoria Mateos; Paula Rodriguez-Otero; Sham Mailankody; Weijun Fu; Ryan Yann Shern Keh; Bianca D. Santomasso; Jaszianne Tolbert; William Terry; Fatema Malbari; Stacy Sowers; Yadgiri Rao Danda; Murali Janakiram
delete分享
delete收藏
“Whole-Blood Epstein–Barr Virus DNA in Immunocompetent Primary CNS Lymphoma patients: A Prospective Exploratory Case–Control Study”外周血中免疫健全的原发性中枢神经系统淋巴瘤患者的EB病毒DNA：一项前瞻性探索性病例对照研究
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-27
delete0
PREAI
deleteSofia Singh; Diksha Rana; Prabhjit Kaur; Raghav Lal; Karthik Vinay Mahesh; Debajyoti Chatterjee; Seema Chabra; Aastha Takkar; Gaurav Prakash; Ranjana W. Minz
delete分享
delete收藏
Bone Marrow Fibrosis Is Associated with Inferior Survival in Lower-Risk Myelodysplastic Syndromes and Adds Prognostic Information to IPSS-R and IPSS-M骨髓纤维化与低风险骨髓增生异常综合征的不良生存相关，并增加了IPSS-R和IPSS-M的预后信息
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-27
delete0
PREAI
deleteArda Bayar; Muhammed Fatih Kırcalı; Fatma Temiz; Ceren Uzunoğlu Güren; Rana Berru Özince; Semih Özerol; İdil Pekpergel; Şevval Tekin; Elif Sakcı; Fatma Arıkan; Pınar Ata; Asu Fergün Yılmaz; Işık Atagündüz; Tayfur Toptaş
delete分享
delete收藏
Right ventricular global longitudinal strain derived by cardiac magnetic resonance in cardiac light-chain amyloidosis: improved prognostic model fit beyond staging and greater discrimination than echocardiography — a retrospective cohort study通过心脏磁共振测量的右心室整体纵向应变在心脏轻链淀粉样变性中的应用：在分期基础上改进预后模型拟合度并优于超声心动图——一项回顾性队列研究
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-23
delete0
PREAI
deleteVasilis Mikros; Niki Lama; Georgios Georgiopoulos; Ioannis Petropoulos; Fenia Theodorakakou; Peggy Kostakou; Ioannis Boutsikos; Anna Dimoula; Raphael Patras; Angeliki Alifragki; Nikolaos Kelekis; Meletios A. Dimopoulos; Efstathios Kastritis; Kimon Stamatelopoulos; Alexandros Briasoulis
delete分享
delete收藏
GPRC5D-directed antibodies in multiple myeloma: new agents and frontline strategies from IMS 2026GPRC5D靶向抗体在多发性骨髓瘤中的应用：IMS 2026会议上的新药和一线策略
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-21
delete0
PREAI
deleteChangnian Li; Siyuan Cui
delete分享
delete收藏
Consolidation with hyper-CVAD or VP plus dasatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Randomized Controlled Trial使用hyper-CVAD或VP联合达沙替尼进行费城染色体阳性急性淋巴细胞白血病的巩固治疗：一项随机对照试验
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-19
delete0
PREAI
deleteXiaoyan Zheng; Ruimin Liu; Juan Ren; Huachao Zhu; Pencheng He; Xiaoning Wang
delete分享
delete收藏
How Many Lines of Therapy Do Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receive in Routine Clinical Practice in the United States? Real World Evidence from the Targeted Therapy Era在美国常规临床实践中，慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者接受了多少线治疗？靶向治疗时代的真实世界证据
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-14
delete0
deleteOAAI
deleteDeborah M. Stephens; Moshe Yair Levy; Naleen Raj Bhandari; Tomoko Sugihara; Baoyi Feng; Inhye E. Ahn; Tara Graff; Katherine B Winfree; Bita Fakhri; Erin E. Lampson; Mohsen Soltanifar; Ian Flinn; Sarang Abhyankar; Paolo Abada; Sameer A. Parikh
delete分享
delete收藏
FcRH5-targeted therapy in multiple myeloma: evolving clinical strategies and resistance from IMS 2026FcRH5靶向疗法在多发性骨髓瘤中的应用：不断发展的临床策略和IMS 2026耐药性
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-13
delete0
PREAI
deleteChangnian Li; Jingjing Pan
delete分享
delete收藏
Health-related quality of life with mosunetuzumab plus polatuzumab vedotin in R/R LBCL: Phase 3 SUNMO trialmosunetuzumab联合polatuzumab vedotin在R/R LBCL中的健康相关生活质量：III期SUNMO试验
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-12
delete0
deleteOAAI
deleteWon-Seog Kim; Huilai Zhang; Dai Maruyama; Astrid Pavlovsky; Eduardo M. Rego; Huangming Hong; Hideki Goto; Mark Fesler; Boone Goodgame; Zhiming Li; Adam J. Olszewski; Joan Ashby; Shen Yin; Wahib S. Ead; Martin Janousek; Song Pham; Connie L. Batlevi; Michael C. Wei; Jason Westin; Lihua E. Budde
delete分享
delete收藏
Real-world experience of using next-generation-sequencing in Multiple Myeloma diagnostics in the UK National Health Service.英国国民健康服务体系中下一代测序在多发性骨髓瘤诊断中的实际应用经验
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-12
delete0
PREAI
deleteSina A Beer; Elisa Senaca; Giuseppe Bertuglia; Paula Proszek; Tracey Thornton; Michael Hubank; Mikel Valganon Patrizan; Dima El-Sharkawi; Katy Smith; Charlotte Pawlyn; Kevin Boyd; Martin F Kaiser
delete分享
delete收藏
Favorable safety and efficacy of duvelisib maintenance after autologous stem cell transplant in peripheral T-cell lymphomas自体干细胞移植后外周T细胞淋巴瘤患者使用杜维利司维持治疗的安全性与有效性良好
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-12
delete0
deleteOAAI
deleteHunter Cochran; Ningying Wu; Raya Saba; Neha Mehta-Shah; Armin Ghobadi; John F. DiPersio; Amanda F. Cashen
delete分享
delete收藏
Patient-Reported Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Glofitamab plus Gemcitabine and Oxaliplatin in STARGLO在STARGLO研究中，接受Glofitamab联合吉西他滨和奥沙利铂治疗复发或难治性弥漫性大B细胞淋巴瘤患者的患者报告结局
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-11
delete0
deleteOAAI
deleteGareth P. Gregory; Jeremy S. Abramson; Huiqiang Huang; Qingyuan Zhang; Matthew Ku; Dok Hyun Yoon; Christopher P. Fox; Haifaa Abdulhaq; William Townsend; Joan Ashby; Alana Harris; Estefania Mulvihill; Martine Kallemeijn; Murali Kesavan; Richard Ta; Voleak Choeurng; Linda Lundberg; Huilai Zhang
delete分享
delete收藏
SOHO State of the Art Updates and Next Questions | Best of Cell Therapy for LymphomaSOHO 技术前沿更新与后续问题 | 淋巴瘤细胞疗法的最佳实践
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-06
delete0
PREAI
deleteHanan Alharthy; Sairah Ahmed
delete分享
delete收藏
Twenty-Five Years of CML Therapy in India: A Model for Precision Oncology in a Resource-Constrained Setting印度慢性粒细胞白血病的25年治疗：资源受限环境下的精准肿瘤学模式
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-10-01
delete0
PREAI
deletePooja Chauhan; Prateek Bhatia; Viji Venkatesh; Deepak Bansal; Shano Naseem; Nitya Malhotra; Pranay Juneja; Charanpreet Singh; Aditya Jandial; Jyoti Dixit; Arihant Jain; Gaurav Prakash; Shankar Prinja; Alka Khadwal; Pankaj Malhotra
delete分享
delete收藏
Asciminib after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia: a multicenter real-world experience异基因造血干细胞移植后慢性粒细胞白血病患者使用Asciminib：一项多中心真实世界研究经验
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-09-30
delete0
PREAI
deleteYulia Vlasova; Nikita Volkov; Elena Morozova; Elza Lomaia; Ekaterina Ovsyannikova; Anna Turkina; Ekaterina Chelysheva; Elena Kuzmina; Anna Petrova; Larisa Kuzmina; Ksenia Tsvirko; Tatiana Rudakova; Ksenia Muslimova; Tatiana Gindina; Valeria Katerina; Ivan Moiseev; Alexander Kulagin
delete分享
delete收藏
Cardiovascular Toxicities of Contemporary Cancer Immunotherapies: A Narrative Review of Immune Checkpoint Inhibitors, Bispecific T-Cell Engagers, and CAR-T Cell Therapies当代癌症免疫疗法的心血管毒性：关于免疫检查点抑制剂、双特异性T细胞结合剂和CAR-T细胞疗法的故事性综述
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-09-30
delete0
PREAI
deleteJean El Cheikh; Bahaa El Deen Wehbeh; Ali Tarhini; Ralf Mansour; Georgio Sayde; Nicole Charbel; Katia Kautaich; Ibrahim Hasan; Marwan M. Refaat
delete分享
delete收藏
The use of Bruton-tyrosine kinase inhibitors in non-IgM lymphoplasmacytic lymphoma: a retrospective Italian study布鲁顿酪氨酸激酶抑制剂在非IgM淋巴浆细胞样淋巴瘤中的应用：一项意大利回顾性研究
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-09-25
delete0
PREAI
deleteAlessandro Noto; Nicolò Danesin; Adalberto Ibatinici; Michele Merli; Raffaella Pasquale; Michela Schirru; Emanuele Cencini; Silvia Ferrari; Gloria Margiotta Casaluci; Maura Nicolosi; Marina Deodato; Arianna Zappaterra; Roberto Cairoli; Francesco Piazza; Marzia Varettoni; Alessandra Tedeschi; Anna Maria Frustaci
delete分享
delete收藏
SOHO State of the Art Updates and Next Questions | The Evolving AML Treatment ParadigmSOHO 现有技术更新与下一阶段问题 | 持续发展的 AML 治疗范式
deleteClinical Lymphoma Myeloma and Leukemia
IF2.7
delete2026-09-25
delete0
PREAI
deleteElyse A. Olesinski; Brandon J. Aubrey; Amir T. Fathi
delete分享
delete收藏